|
| |
Sage Group
Expands Team – Dr. Josef Bossart Joins As New Executive Director
March 8, 2005:
The Sage Group (
www.sagehealthcare.com
), an international business strategy and transaction company, is pleased
to announce that Dr. Josef Bossart has joined the company as Executive Director.
Dr. Bossart has extensive experience in the biopharmaceutical sector working
with, and for, companies in the area of business and corporate development.
Dr. Bossart most recently was founder and principal of Bossart4 Bioconsult where
he assisted clients in developing and executing corporate development and
partnering plans. His earlier experience includes positions as Vice President of
Business Development and President SCA Ventures, both with Enzon
Pharmaceuticals, and Chief Business Officer of GeneMedicine. His pharma
experience includes fifteen years with the Rhône-Poulenc Pharma group where he
held a series of marketing, sales, business development and general management
roles, most recently as Vice President of Business and Marketing Development for
RPR Gencell.
“I look forward to working with the partners at The Sage Group to build on their
broad international experience in helping clients meet their business goals”,
said Dr. Bossart. “With personnel and resources spanning three continents, The
Sage Group is in a uniquely strong position to help client companies meet their
business objectives.” Wayne Pambianchi, Executive Director of The Sage Group,
said “The addition of Dr. Bossart to the Sage Team will expand the expertise and
range of services we offer our clients. In addition to his broad experience in
the biopharma segment he brings the group particular experience and contacts in
the area of drug delivery. We expect he will be ideally suited to help our
clients meet their business and corporate development goals. In addition to his
strong operational skills, Bossart is particularly interested in the analytical
and strategic aspects of corporate development. His business development
articles in the journal Drug Delivery Technology, targeted to the drug delivery
sector, provide a template for better understanding and capturing the clinical
and business opportunities of the biopharma sector.”
The Sage Group Inc. is a leader in the provision of strategic and transactional
advice to health care companies in the diagnostics, medical device,
pharmaceutical, biotechnology and life science fields.
Since it’s founding in 1994, The Sage Group has served more than 100 clients in
the US, Europe and Asia, and completed numerous transactions including
financings, alliances, acquisitions and divestitures with values ranging from $5
million to $100 million. The establishment of operations in Europe and Japan
allows its clients to reach out beyond their own regions and capture the
potential of the global healthcare market.
Sage Group can be contacted at either of the offices shown below:
US Corporate Offices European Corporate Offices
The Sage Group Inc.
3322 Route 22 West
Building 2, Suite 201
Branchburg, NJ 08876 US
Attn.: Wayne Pambianchi
Phone: +1 908 2319644
Fax: +1 908 2319692
Email: wpambianch@aol.com
Sage Healthcare Ltd.
Church Street Barns
Great Shelford
Cambridge CB2 5EL UK
Attn.: Dr. Bill Mason
Phone: +44 (0) 1223 844128
Fax: +44 (0) 1223 847871
Email: wtm@sagehealthcare.com
| |
|
